CONCENTRA BIOSCIENCES, LLC enters JOUNCE THERAPEUTICS, INC. with 36.37M shares across direct and indirect positions
This filing by CONCENTRA BIOSCIENCES, LLC establishes the baseline for all future Form 4 insider transaction reports at JOUNCE THERAPEUTICS, INC..
Indirect
Filed: 5/5/2023ACC: 0001209191-23-027685
10% Owner
Since May 2023
36.37M
Baseline shares
0.00
Direct ownership
0 positions
0.00
Derivative underlying
0 instruments
1
Security positions
36.37M indirect
Non-Derivative Holdings1
Common Stock
IndirectShares owned36.37M
Total
36.37M indirect36.37M
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 36.37M | Indirect |
| Total | 36.37M | 36.37M indirect |
Derivative Holdings0
No derivative holdings reported